The White House denied that the single approval of Eli Lilly's highly-anticipated weight loss drug retatrutide was for Trump after a STAT report.

A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.

A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it was made in April.